Announcement of Chems Hachani, CEO of ECLEVAR, Participation in Oracle’s Webinar
Oracle is pleased to announce the participation of Chems Hachani, CEO of ECLEVAR, in the upcoming webinar “Empowering CROs: Leveraging Cutting-Edge Technologies for Enhanced Clinical Trial Efficiency and Sponsor Partnerships” on March 13, 2025, from 11:00 AM to 12:00 PM ET.
As Clinical Research Organizations (CROs) face increasing pressure to deliver high-quality results faster and more efficiently, this webinar will explore how cutting-edge technologies can optimize sponsor partnerships, improve patient recruitment, streamline trial processes, and enhance data management through AI-driven cloud solutions and decentralized trials.
Chems Hachani will share insights and expertise on how innovative technologies are transforming clinical trial operations, improving collaboration with sponsors, and driving greater efficiency across the trial lifecycle.
Event Speakers:
Laurence Maunier – Sr. Manager, Data Management & FSP Platform Manager, Excelya
Baljit Klear – Alliances & Channels Director, Oracle Life Sciences
Chems Hachani – CEO, Eclevar Medtech
Meg Richie – Vice President, Global Clinical Data Management
Key Learning Objectives:
- Understand how integrated clinical trial platforms streamline workflows and enhance collaboration across the trial lifecycle.
- Explore technologies for optimizing patient recruitment, remote participation, and improved engagement.
- Learn how real-time data analytics facilitate faster, data-driven decision-making in clinical trials.
- Evaluate the role of scalable cloud infrastructure in supporting trials of varying sizes and complexities.
- Discuss data and technology options when relationships between stakeholders evolve.
We invite all industry professionals to join this webinar and discover how innovative technological solutions can shape the future of clinical trials.
Don’t miss this unique opportunity to gain valuable insights from leading industry experts!
Register here: Oracle Webinar Registration
